FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973455581> ?p ?o ?g. }

• W1973455581 endingPage "1078" @default.
• W1973455581 startingPage "1078" @default.
• W1973455581 abstract "Purpose: We evaluated the efficacy and safety of combined therapy with an alpha-blocker (tamsulosin 0.2 mg) and low-dose anti-cholinergics (propiverine HCl 10 mg) in patients with benign prostatic hyperplasia (BPH) accompanied by overactive bladder (OAB) symptoms. Materials and Methods: This prospective study enrolled 119 male patients with lower urinary tract symptoms (LUTS) with prostate volume of 20 ml or greater, International Prostate Symptom Score (IPSS) of more than 8, and OAB symptoms from May 2007 to April 2008. Patients with post-void residual volume (PVR) over 100 ml were excluded. Among these patients, 74 patients were treated with tamsulosin 0.2 mg plus propiverine HCl 10 mg (group A) and 45 patients were treated with tamsulosin 0.2 mg only (group B). The clinical parameters, including IPSS, quality of life (QoL) score, uroflowmetry, and PVR were re-evaluated after 3 months. Results: A total of 115 patients, including 70 in group A and 45 in group B, completed the study. IPSS, QoL score, voided volume, maximum flow rate (Qmax), and PVR showed significant improvement after 3 months of treatment (p 0.05). Changes in the QoL score were −1.9±1.1 and −1.5±0.9 for group A and group B, respectively (p=0.043). Changes in all other parameters were not significantly different between the 2 groups (p>0.05). Conclusions: For those patients with LUTS due to BPH and concomitant OAB, combination therapy with an alpha-blocker (tamsulosin 0.2 mg) and low-dose anti-cholinergics (propiverine HCl 10 mg) may be a reasonable and effective therapeutic option as an initial therapy. (Korean J Urol 2009;50:1078-1082) 󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏" @default.
• W1973455581 created "2016-06-24" @default.
• W1973455581 creator A5045776973 @default.
• W1973455581 creator A5058446290 @default.
• W1973455581 creator A5067113181 @default.
• W1973455581 date "2009-01-01" @default.
• W1973455581 modified "2023-10-16" @default.
• W1973455581 title "The Efficacy and Safety of Combination Therapy with Alpha-Blocker and Low-Dose Propiverine Hydrochloride for Benign Prostatic Hyperplasia Accompanied by Overactive Bladder Symptoms" @default.
• W1973455581 cites W1585489386 @default.
• W1973455581 cites W1971081113 @default.
• W1973455581 cites W2009972129 @default.
• W1973455581 cites W2010616721 @default.
• W1973455581 cites W2011746657 @default.
• W1973455581 cites W2011962188 @default.
• W1973455581 cites W2017922615 @default.
• W1973455581 cites W2022422644 @default.
• W1973455581 cites W2022852494 @default.
• W1973455581 cites W2065814656 @default.
• W1973455581 cites W2078997630 @default.
• W1973455581 cites W2081313560 @default.
• W1973455581 cites W2089437227 @default.
• W1973455581 cites W2090157534 @default.
• W1973455581 cites W2106455438 @default.
• W1973455581 cites W2123278711 @default.
• W1973455581 cites W2134121470 @default.
• W1973455581 cites W2168942726 @default.
• W1973455581 cites W2411922780 @default.
• W1973455581 cites W4236163484 @default.
• W1973455581 doi "https://doi.org/10.4111/kju.2009.50.11.1078" @default.
• W1973455581 hasPublicationYear "2009" @default.
• W1973455581 type Work @default.
• W1973455581 sameAs 1973455581 @default.
• W1973455581 citedByCount "6" @default.
• W1973455581 countsByYear W19734555812012 @default.
• W1973455581 countsByYear W19734555812013 @default.
• W1973455581 countsByYear W19734555812014 @default.
• W1973455581 countsByYear W19734555812021 @default.
• W1973455581 crossrefType "journal-article" @default.
• W1973455581 hasAuthorship W1973455581A5045776973 @default.
• W1973455581 hasAuthorship W1973455581A5058446290 @default.
• W1973455581 hasAuthorship W1973455581A5067113181 @default.
• W1973455581 hasBestOaLocation W19734555811 @default.
• W1973455581 hasConcept C126322002 @default.
• W1973455581 hasConcept C126894567 @default.
• W1973455581 hasConcept C142724271 @default.
• W1973455581 hasConcept C204787440 @default.
• W1973455581 hasConcept C2777562237 @default.
• W1973455581 hasConcept C2778941218 @default.
• W1973455581 hasConcept C71924100 @default.
• W1973455581 hasConceptScore W1973455581C126322002 @default.
• W1973455581 hasConceptScore W1973455581C126894567 @default.
• W1973455581 hasConceptScore W1973455581C142724271 @default.
• W1973455581 hasConceptScore W1973455581C204787440 @default.
• W1973455581 hasConceptScore W1973455581C2777562237 @default.
• W1973455581 hasConceptScore W1973455581C2778941218 @default.
• W1973455581 hasConceptScore W1973455581C71924100 @default.
• W1973455581 hasIssue "11" @default.
• W1973455581 hasLocation W19734555811 @default.
• W1973455581 hasOpenAccess W1973455581 @default.
• W1973455581 hasPrimaryLocation W19734555811 @default.
• W1973455581 hasRelatedWork W140645618 @default.
• W1973455581 hasRelatedWork W1989849806 @default.
• W1973455581 hasRelatedWork W1997625193 @default.
• W1973455581 hasRelatedWork W2321596222 @default.
• W1973455581 hasRelatedWork W2356928667 @default.
• W1973455581 hasRelatedWork W2392413698 @default.
• W1973455581 hasRelatedWork W2417747179 @default.
• W1973455581 hasRelatedWork W2890760624 @default.
• W1973455581 hasRelatedWork W2921229903 @default.
• W1973455581 hasRelatedWork W3021969062 @default.
• W1973455581 hasVolume "50" @default.
• W1973455581 isParatext "false" @default.
• W1973455581 isRetracted "false" @default.
• W1973455581 magId "1973455581" @default.
• W1973455581 workType "article" @default.